Please enable JavaScript to continue using this application.

Compare $ARMP vs $OTLK | Chartloom

Compare

$ARMP vs $OTLK

Armata Pharmaceuticals Inc · Outlook Therapeutics Inc

ARMP

Armata Pharmaceuticals Inc

OTLK

Outlook Therapeutics Inc

Compare $ARMP vs $OTLK

Comparing Armata Pharmaceuticals Inc and Outlook Therapeutics Inc

ARMPArmata Pharmaceuticals Inc

OTLKOutlook Therapeutics Inc

ARMPArmata Pharmaceuticals Inc

Market cap

$133M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.3%

YTD performance

-44.7%

52W performance

12.7%

FCF yield

-19.4%

OTLKOutlook Therapeutics Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.58x

Rev growth (TTM)

-171.2%

YTD performance

-9.3%

52W performance

-52.5%

FCF yield

-50.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARMP

OTLK

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

OTLK

Outlook Therapeutics Inc

Market Cap

ARMP$133M

OTLK$112M

Enterprise Value

ARMP$393M

OTLK$119M

Price

ARMP$3.63

OTLK$0.60

P/E Ratio

ARMPN/A

OTLKN/A

P/S Ratio

ARMP24.04x

OTLK0.00x

EV/Sales

ARMP70.87x

OTLK1,109.27x

EV/EBITDA

ARMP0.00x

OTLK0.00x

P/B Ratio

ARMP6.85x

OTLK13.76x

P/FCF Ratio

ARMPN/A

OTLKN/A

EV/FCF

ARMP-15.23x

OTLK-2.12x

PEG Ratio

ARMPN/A

OTLKN/A

Forward P/E (NTM)

ARMPN/A

OTLKN/A

Forward P/S (NTM)

ARMPN/A

OTLK3.58x

Revenue (TTM)

ARMP$6M

OTLK$-1M

Revenue Growth (YoY)

ARMP-19.3%

OTLK-171.2%

Forward Rev Growth

ARMP-35.3%

OTLK26.4%

Gross Margin (TTM)

ARMP0.0%

OTLK203.8%

Operating Margin (TTM)

ARMP0.0%

OTLK0.0%

EBITDA Margin (TTM)

ARMP-603.4%

OTLK5181.7%

Net Margin (TTM)

ARMP-3467.0%

OTLK5703.4%

FCF Margin (TTM)

ARMP-465.3%

OTLKN/A

Net Income (TTM)

ARMP$-192M

OTLK$-61M

FCF (TTM)

ARMP$-26M

OTLK$-56M

EPS (TTM)

ARMP-$3.10

OTLK-$0.45

ROE (TTM)

ARMP-12000.0%

OTLK-41551.0%

ROA (TTM)

ARMP-23569.0%

OTLK-28798.0%

ROIC (TTM)

ARMP-8123.0%

OTLK-16327.0%

Cash

ARMP$24M

OTLK$11M

Debt

ARMP$284M

OTLK$18M

Net Cash/Debt

ARMP$-260M

OTLK$-7M

Current Ratio (TTM)

ARMP0.11x

OTLK0.81x

Quick Ratio (TTM)

ARMP0.11x

OTLK0.45x

Debt/Equity (TTM)

ARMP1.38x

OTLK3.04x

Debt/Assets (TTM)

ARMP0.0%

OTLK0.0%

Interest Coverage (TTM)

ARMPN/A

OTLKN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

OTLK0.00x

Beta

ARMP1.66

OTLK0.64

52W Performance

ARMP12.7%

OTLK-52.5%

YTD Performance

ARMP-44.7%

OTLK-9.3%

% from 52W High

ARMP-77.8%

OTLK-76.4%

% from 52W Low

ARMP17.5%

OTLK271.8%

Asset Turnover (TTM)

ARMP0.07x

OTLK0.01x

FCF Yield (TTM)

ARMP-19.4%

OTLK-50.1%

Earnings Yield (TTM)

ARMP-144.2%

OTLK-54.6%

Dividend Yield (TTM)

ARMPN/A

OTLKN/A

Rule of 40

ARMP-484.6

OTLK5,010.5

EV/GP/RG

ARMPN/A

OTLKN/A

Ticker research

View ARMP research View OTLK research

Metric	ARMP Armata Pharmaceuticals Inc	OTLK Outlook Therapeutics Inc
Market & Valuation
Market Cap	$133M	$112M
Enterprise Value	$393M	$119M
Price	$3.63	$0.60
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	0.00x
EV/Sales	70.87x	1,109.27x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	13.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-2.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.58x
Revenue & Growth
Revenue (TTM)	$6M	$-1M
Revenue Growth (YoY)	-19.3%	-171.2%
Forward Rev Growth	-35.3%	26.4%
Profitability
Gross Margin (TTM)	0.0%	203.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	5181.7%
Net Margin (TTM)	-3467.0%	5703.4%
FCF Margin (TTM)	-465.3%	N/A
Net Income (TTM)	$-192M	$-61M
FCF (TTM)	$-26M	$-56M
EPS (TTM)	-$3.10	-$0.45
ROE (TTM)	-12000.0%	-41551.0%
ROA (TTM)	-23569.0%	-28798.0%
ROIC (TTM)	-8123.0%	-16327.0%
Financial Health
Cash	$24M	$11M
Debt	$284M	$18M
Net Cash/Debt	$-260M	$-7M
Current Ratio (TTM)	0.11x	0.81x
Quick Ratio (TTM)	0.11x	0.45x
Debt/Equity (TTM)	1.38x	3.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	0.64
52W Performance	12.7%	-52.5%
YTD Performance	-44.7%	-9.3%
% from 52W High	-77.8%	-76.4%
% from 52W Low	17.5%	271.8%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.01x
FCF Yield (TTM)	-19.4%	-50.1%
Earnings Yield (TTM)	-144.2%	-54.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	5,010.5
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View OTLK research

Valuation

P/S Ratio

OTLK

0.00x

ARMP

24.04x

EV/FCF

ARMP

-15.23x

OTLK

-2.12x

Growth & revenue

Revenue Growth TTM

ARMP

-19.3%

OTLK

-171.2%

Forward Revenue Growth

OTLK

26.4%

ARMP

-35.3%

Profitability & performance

Gross Margin

OTLK

203.8%

ARMP

0.0%

ROE

ARMP

-12000.0%

OTLK

-41551.0%

FCF Yield %

ARMP

-19.4%

OTLK

-50.1%

52-Week Performance

ARMP

12.7%

OTLK

-52.5%

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

OTLK

Outlook Therapeutics Inc

Market Cap

ARMP$133M

OTLK$112M

Enterprise Value

ARMP$393M

OTLK$119M

Price

ARMP$3.63

OTLK$0.60

P/E Ratio

ARMPN/A

OTLKN/A

P/S Ratio

ARMP24.04x

OTLK0.00x

EV/Sales

ARMP70.87x

OTLK1,109.27x

EV/EBITDA

ARMP0.00x

OTLK0.00x

P/B Ratio

ARMP6.85x

OTLK13.76x

P/FCF Ratio

ARMPN/A

OTLKN/A

EV/FCF

ARMP-15.23x

OTLK-2.12x

PEG Ratio

ARMPN/A

OTLKN/A

Forward P/E (NTM)

ARMPN/A

OTLKN/A

Forward P/S (NTM)

ARMPN/A

OTLK3.58x

Revenue (TTM)

ARMP$6M

OTLK$-1M

Revenue Growth (YoY)

ARMP-19.3%

OTLK-171.2%

Forward Rev Growth

ARMP-35.3%

OTLK26.4%

Gross Margin (TTM)

ARMP0.0%

OTLK203.8%

Operating Margin (TTM)

ARMP0.0%

OTLK0.0%

EBITDA Margin (TTM)

ARMP-603.4%

OTLK5181.7%

Net Margin (TTM)

ARMP-3467.0%

OTLK5703.4%

FCF Margin (TTM)

ARMP-465.3%

OTLKN/A

Net Income (TTM)

ARMP$-192M

OTLK$-61M

FCF (TTM)

ARMP$-26M

OTLK$-56M

EPS (TTM)

ARMP-$3.10

OTLK-$0.45

ROE (TTM)

ARMP-12000.0%

OTLK-41551.0%

ROA (TTM)

ARMP-23569.0%

OTLK-28798.0%

ROIC (TTM)

ARMP-8123.0%

OTLK-16327.0%

Cash

ARMP$24M

OTLK$11M

Debt

ARMP$284M

OTLK$18M

Net Cash/Debt

ARMP$-260M

OTLK$-7M

Current Ratio (TTM)

ARMP0.11x

OTLK0.81x

Quick Ratio (TTM)

ARMP0.11x

OTLK0.45x

Debt/Equity (TTM)

ARMP1.38x

OTLK3.04x

Debt/Assets (TTM)

ARMP0.0%

OTLK0.0%

Interest Coverage (TTM)

ARMPN/A

OTLKN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

OTLK0.00x

Beta

ARMP1.66

OTLK0.64

52W Performance

ARMP12.7%

OTLK-52.5%

YTD Performance

ARMP-44.7%

OTLK-9.3%

% from 52W High

ARMP-77.8%

OTLK-76.4%

% from 52W Low

ARMP17.5%

OTLK271.8%

Asset Turnover (TTM)

ARMP0.07x

OTLK0.01x

FCF Yield (TTM)

ARMP-19.4%

OTLK-50.1%

Earnings Yield (TTM)

ARMP-144.2%

OTLK-54.6%

Dividend Yield (TTM)

ARMPN/A

OTLKN/A

Rule of 40

ARMP-484.6

OTLK5,010.5

EV/GP/RG

ARMPN/A

OTLKN/A

Ticker research

View ARMP research View OTLK research

Metric	ARMP Armata Pharmaceuticals Inc	OTLK Outlook Therapeutics Inc
Market & Valuation
Market Cap	$133M	$112M
Enterprise Value	$393M	$119M
Price	$3.63	$0.60
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	0.00x
EV/Sales	70.87x	1,109.27x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	13.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-2.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.58x
Revenue & Growth
Revenue (TTM)	$6M	$-1M
Revenue Growth (YoY)	-19.3%	-171.2%
Forward Rev Growth	-35.3%	26.4%
Profitability
Gross Margin (TTM)	0.0%	203.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	5181.7%
Net Margin (TTM)	-3467.0%	5703.4%
FCF Margin (TTM)	-465.3%	N/A
Net Income (TTM)	$-192M	$-61M
FCF (TTM)	$-26M	$-56M
EPS (TTM)	-$3.10	-$0.45
ROE (TTM)	-12000.0%	-41551.0%
ROA (TTM)	-23569.0%	-28798.0%
ROIC (TTM)	-8123.0%	-16327.0%
Financial Health
Cash	$24M	$11M
Debt	$284M	$18M
Net Cash/Debt	$-260M	$-7M
Current Ratio (TTM)	0.11x	0.81x
Quick Ratio (TTM)	0.11x	0.45x
Debt/Equity (TTM)	1.38x	3.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	0.64
52W Performance	12.7%	-52.5%
YTD Performance	-44.7%	-9.3%
% from 52W High	-77.8%	-76.4%
% from 52W Low	17.5%	271.8%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.01x
FCF Yield (TTM)	-19.4%	-50.1%
Earnings Yield (TTM)	-144.2%	-54.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	5,010.5
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View OTLK research